Home-Based Hospital Care Program for Adults with Decompensated Cirrhosis A New Way to Manage Liver Disease Outside the Hospital

What this Trial Is About

Researchers are evaluating the Hospital at Home HH program as a new care model for patients with end-stage liver disease, specifically those with decompensated cirrhosis. The study aims to understand patients perspectives on this home-based care approach, including their expectations, barriers, and desired outcomes. This program extends traditional hospital care by providing acute medical and rehabilitation services in the home, potentially improving patient and caregiver satisfaction while reducing healthcare utilization and costs. The study is divided into three phases. Phase 1 occurs while the participant is still an inpatient, during which patient-reported outcomes are assessed through questionnaires and interviews. Phase 2 involves the clinical delivery of the HH program, where participants receive hospital-level care at home with support from healthcare providers using remote monitoring devices and in-person or virtual visits. Phase 3 focuses on rehabilitation and transitioning the patient to self-management, including virtual research discussions and quality of life assessments. Participants will engage in questionnaires, interviews, and virtual sessions to evaluate their experience and outcomes with the HH program. Researchers will monitor follow-up visits, emergency department visits, rehospitalizations, and mortality rates over periods up to 90 days post-program. Caregiver involvement is also assessed during the acute phase of care. The study collects data over two years to review program enrollment and participant outcomes, aiming to provide insights into the safety, satisfaction, and effectiveness of home-based care for cirrhosis.

Hospital @ Home Model of Care for Cirrhosis